Home / News Center / Policy & Regulation
News Center · Policy & RegulationZhejiang Rewrites the Filing Rulebook in 20 Measures, Live From 15 November
*MZ Toutiao (美妆头条) · 2026-10-28 · Policy / Filing* **原文:** 浙江省药监局印发20条化妆品监管改革举措,11月15日起施行 Zhejiang's medical products regulator has issued 20 measures on cosmetic supervision reform, grouped under four headings — quality, supervision efficiency, industry capability and support — with an effective date of 15 November. The province is not a marginal market: full-chain cosmetic sales reached RMB 130.2bn in 2025, exports rank second nationally, and output and exports both grew at double-digit rates in the first half of 2026. That weight is why the filing mechanics matter beyond Zhejiang. Three provisions stand out. Ordinary cosmetics filing moves to a fast-track channel, ingredient dossiers are simplified, and products with near-identical formulas may share safety and efficacy data — a real cost cut for portfolios built on one base. Electronic labels move from pilot to broader use. And imported debut products launched in Zhejiang may be exempted from submitting proof of sale in the origin market, the single most concrete opening here for foreign brands. Online governance, credit-tiered supervision and Yangtze Delta coordination round out the package, framed against the province's fifte
Related
Regulatory View: Compliance Paths and Standards for Soluble Microcrystal Patches
Dissolving microneedle products face a dual regulatory path of cosmetics versus medical devices:…
E-commerce sampling compliance rate rises: Where the next growth curve lies
E-commerce sampling compliance rate rises has been gaining momentum. Data shows that in Q4, onli…
Children’s cosmetics rules tighten further: Reading competitive dynamics from the supply side
Children’s cosmetics rules tighten further has been gaining momentum. Data shows that in Q3, new…
New ingredient filings hit a record high: New dividends from shifting channels
New ingredient filings hit a record high has been gaining momentum. Data shows that in Q2, top-b…